[ad_1]
- Bruker press launch (NASDAQ:BRKR): Q2 Non-GAAP EPS of $0.52 beats by $0.01.
- Income of $800.7M (+17.4% Y/Y) beats by $2.88M.
-
For FY 2024, Bruker now expects revenues of $3.38 to $3.44 billion (prior $3.29 to $3.35 billion) vs. $3.40B consensus, in comparison with FY 2023 revenues of $2.96 billion, with 14% to 16% year-over-year reported income progress, together with contributions from:
- Natural income progress of 5% to 7%,
- An M&A tailwind of roughly 10%,
- A international foreign money translation income headwind of roughly -1%,
- CER income progress of 15% to 17%.
Bruker now expects FY 2024 non-GAAP EPS of $2.59 to $2.64 (prior $2.79 to $2.84) vs. $2.63 consensus, in comparison with FY 2023 non-GAAP EPS of $2.58.
Up to date FY 2024 income and non-GAAP EPS steerage is predicated on international foreign money alternate charges as of June 30, 2024.
[ad_2]
2024-08-06 11:23:20
Source :https://seekingalpha.com/information/4134738-bruker-beats-top-line-and-bottom-line-estimates-raises-fy24-revenue-outlook?utm_source=feed_news_all&utm_medium=referral&feed_item_type=information
Discussion about this post